Finance

Lists
1541:HKG
ImmuneOnco Biopharmaceuticals(Shngh) Inc
HK$3.53
+3.82%
(+0.13) 1D
Sep 7, 4:00:00 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1541...
Open
HK$3.36
High
HK$3.59
Low
HK$3.35
Mkt. cap
1.52B
Avg. vol.
0.00
Volume
348.40K
52-wk high
HK$16.80
52-wk low
HK$2.80
EPS
-HK$0.63
No. of employees
197
Open
HK$3.36
High
HK$3.59
Low
HK$3.35
Mkt. cap
1.52B
Avg. vol.
0.00
Volume
348.40K
52-wk high
HK$16.80
52-wk low
HK$2.80
EPS
-HK$0.63
No. of employees
197
About ImmuneOnco Biopharmaceuticals(Shngh) Inc
CEO-
Employees197
Founded2015
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
55.14M
55.14M
18.62M
18.62M
Cost of goods sold
555.00K
555.00K
-
-
Cost of revenue
555.00K
555.00K
-
-
Research and development expenses
77.12M
77.12M
77.39M
77.39M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.34M
13.34M
11.60M
11.60M
Operating expense
90.46M
90.46M
88.99M
88.99M
Total operating expenses
91.01M
91.01M
88.99M
88.99M
Operating income
-35.87M
-35.87M
-70.36M
-70.36M
Other non operating income
4.90M
4.90M
-6.50K
-6.50K
EBT including unusual items
-33.27M
-33.27M
-82.74M
-82.74M
EBT excluding unusual items
-33.47M
-33.47M
-77.67M
-77.67M
Income tax expense
14.50K
14.50K
11.50K
11.50K
Effective tax rate
-0.04%
-0.04%
-0.01%
-0.01%
Other operating expenses
-
-
-
-
Net income
-33.00M
-33.00M
-82.09M
-82.09M
Net profit margin
-59.84%
-59.84%
-440.81%
-440.81%
Earnings per share
-
-
-
-
Interest and investment income
1.57M
1.57M
2.28M
2.28M
Interest expense
-1.43M
-1.43M
-2.12M
-2.12M
Net interest expenses
136.00K
136.00K
165.50K
165.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-33.84M
-33.84M
-68.28M
-68.28M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps